Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Event-Driven

<a href="https://www.smartkarma.com/entities/881" target="_blank" data-smartkarma-citation="entities:881:1">Fortis Healthcare Ltd (FORH IN)</a> reported unaudited Q4 and FY2018 results, disclosed the details of the Luthra &amp; Luthra inquiry, and outlined a strategy to improve financial results post-fundraising. The turnaround plan as proposed is sensible. The main risks relate to initial increases in spending to reinvigorate operations; the challenging regulatory environment; and successfully executing on a broad range of tactics in a relatively short period of time.
The company has moved the bid deadline to 3 July, so our discussion focuses on the updated current situation along with management's proposed turnaround plan.
We tag this Insight as bearish because we think that bids for the company are unlikely to increase.

Fortis Healthcare Ltd (FORH IN) reported unaudited Q4 and FY2018 results, disclosed the details of the Luthra &amp; Luthra inquiry, and outlined a strategy to improve financial results post-fundraising. The turnaround plan as proposed is sensible. The main risks relate to initial increases in spending to reinvigorate operations; the challenging regulatory environment; and successfully executing on a broad range of tactics in a relatively short period of time.
The company has moved the bid deadline to 3 July, so our discussion focuses on the updated current situation along with management's proposed turnaround plan.
We tag this Insight as bearish because we think that bids for the company are unlikely to increase.

Fortis Healthcare

Fortis Healthcare: Looking Ahead